News

Apotex Corp. Launches First Generic Oxcarbazepine ER Tablets

Apotex Corp. Launches First Generic Oxcarbazepine ER Tablets

Apotex Corp. Introduces First Generic Oxcarbazepine ER Tablets

Apotex Corp., an affiliate of Apotex Inc. (NASDAQ: APOT), has made a remarkable advancement in the pharmaceutical industry by becoming the first generic manufacturer to launch oxcarbazepine ER tablets, which are a generic version of Oxtellar XR. This launch is a significant milestone for patients looking for effective treatment options for epilepsy.

What Are Oxcarbazepine ER Tablets?

Oxcarbazepine ER tablets are designed as a once-a-day oral anticonvulsant for individuals aged six years and older who suffer from partial-onset seizures. These tablets serve as a vital alternative treatment, aiding in better seizure management and improving the quality of life for those affected.

Commitment to Affordable Healthcare

Michael Bohling, Vice President of Sales & Marketing, shared his pride in Apotex's contributions to the generic pharmaceutical market, stating, "We are delighted to offer a diverse portfolio across various therapeutic areas. This launch reflects our commitment to providing high-quality and cost-effective options for individuals living with seizures." Apotex has a longstanding commitment to ensuring that patients have access to innovative medications at more affordable prices.

About Apotex

Founded in Canada, Apotex is globally recognized for its extensive range of products, which includes generic, biosimilar, and innovative branded pharmaceuticals. With its headquarters in Toronto, the company operates regional offices across the Americas and Asia. As the largest Canadian-based pharmaceutical company, Apotex is a trusted partner for both healthcare providers and patients.

Continuing Innovation

With the introduction of oxcarbazepine ER tablets, Apotex reaffirms its position as a leader in the pharmaceutical sector, consistently innovating and expanding its product offerings. This strategic initiative aims to enhance patient care and provide healthcare professionals with dependable treatment options.

Frequently Asked Questions

What are oxcarbazepine ER tablets used for?

Oxcarbazepine ER tablets are used to treat partial-onset seizures in patients aged 6 and older.

Why is the launch of oxcarbazepine ER important?

This launch is significant as it provides a generic, cost-effective alternative to Oxtellar XR, making treatment more accessible to patients.

What does Apotex do?

Apotex is a global health company that develops innovative medicines and aims to improve access to pharmaceutical products.

Where is Apotex headquartered?

Apotex is headquartered in Toronto, Canada, with regional offices around the globe.

What is the mission of Apotex?

The mission of Apotex is to provide high-quality and affordable medications to enhance patient care and health outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Agiloft Navigates New Growth Phase with Key Leadership

Updated Category News Views 142

Leadership Shifts Steer Agiloft's EMEA Journey Agiloft's latest shake-ups in leadership signal a determined charge through EMEA's bustling markets. Nick Bowles, a seasoned veteran in enterprise software, steps into the limelight as Senior Vice President, while Jim Leason shifts gears into a customer-focused advisory role. These aren’t just routine hiring...

Continue Reading
Pine AI Unveils AI Studio & Real-World Call Feature

Updated Category News Views 107

Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...

Continue Reading
Greenworks Mower Snags Best Electric Award for 2026

Updated Category News Views 72

Greenworks Strikes Again with Top Lawn Mower Honors Man, when I think about the evolution from noisy, gas-guzzling lawn mowers to sleek, battery-powered beasts, Greenworks is right there, leading the charge. Just the other day, Popular Mechanics singled out the Greenworks 80V 22-inch Cordless Lawn Mower, handing it the coveted title of Best Electric Lawn Mower for 2026....

Continue Reading
City National Bank Names New VP for Real Estate

Updated Category News Views 85

Banking on Growth with Jeffrey LaBauve Jeffery LaBauve struts into the picture, ready to take the helm as City National Bank's new head of Commercial Real Estate Banking. And let me tell ya, the word on the street is he's raring to ramp things up. After almost two decades at Comerica Bank, this guy’s not here for a measly lap around the track—he's got plans to double...

Continue Reading
Endava Faces Class Action: Investor Reactions and Next Steps

Updated Category News Views 87

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

Continue Reading
Canadian Solar Gears Up for Q3 2026 Earnings Call

Updated Category News Views 44

Canadian Solar Prepares for Earnings Disclosure Well, strap in, folks. Canadian Solar Inc. (NASDAQ: CSIQ)—a staple in the solar arena—announced that they'll unveil their third quarter 2026 financials on December 3. It's going to be a call worth dialing into. They're holding it right at 8:00 a.m. Eastern Time. You can pop over to their website for a live webcast or go...

Continue Reading
Winterproofing Your Home: Simple Tips to Save Money

Updated Category News Views 51

Winter Is Coming: Time to Prep Your Home When it’s cold enough to freeze a dog's nose, the last place you want a surprise is in your own cozy corner of the world. Quality Heating, Cooling, Plumbing & Electric, the whiz-kids from Glenpool, Oklahoma, are out with some pointers for keeping your house peachy all through winter's tests. We’re talking ways to dodge frozen...

Continue Reading
Purdue's xGTT: Pioneering a New Trust Standard in Tech

Updated Category News Views 129

A Bold New Benchmark in Tech Trust You've got to hand it to the folks at Purdue's Krach Institute—they're not dancing around the fringes but diving straight into the thick of it with their Global Trusted Tech Standard, or xGTT. This isn't just another checkbox for compliance nerds. The xGTT is all about building trust in technology that's woven with democratic values...

Continue Reading
Choosing Dance Styles: Tips from Expert Instructors

Updated Category News Views 115

Navigating the Dance Style Maze Picking a dance style is no joke, especially when every option seems to spin its own tale. It ain't just about twirling to your favorite rhythm. There's a whole spectrum of styles, from graceful ballet to punchy hip-hop, each with its ticklish quirks and temptations. Sandy Young and Jenna Engen, dance experts from Young Dance Academy Inc....

Continue Reading
Data Centers: More Power-Hungry Than Thirsty

Updated Category News Views 134

Data Centers: Not Quite the Water Guzzlers We Feared Hold onto your hats, because the latest intel on data centers is changing the game, or at least forcing a closer look at what seems like a done deal. The big reveal? It's not the water, folks—it’s the juice. While everyone frets about water, electricity is the silent giant you’ve got to wrangle. Water vs....

Continue Reading

Top 5 Most Recently Viewed Articles

Snail, Inc. Delays Q2 2025 Conference Call for Updates

Updated Category News Views 109

Snail, Inc. Postpones Important Financial Call Snail, Inc. (NASDAQ: SNAL), a globally recognized developer and publisher of interactive digital entertainment, has officially announced the postponement of its much-anticipated conference call. This call, originally slated to discuss the company's financial outcomes for the second quarter ending June 30, has been delayed....

Continue Reading
Celebrating Legacy: The Mary S. Phipps Luncheon for Education

Updated Category News Views 190

The Mary S. Phipps Luncheon: A Celebration of Education This year marked a significant milestone as the inaugural Mary S. Phipps Luncheon for Education took place, embracing the legacy of a remarkable figure known for her unwavering commitment to education, leadership, and community service. Under the guidance of dedicated chairs, this event aimed to raise funds that...

Continue Reading
Silexion Therapeutics Unveils Major Breakthrough in Cancer Treatment

Updated Category News Views 216

Silexion Therapeutics Makes Significant Progress in Cancer Research In an exciting development, Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company focused on RNA interference (RNAi) therapies, announced that their product SIL204 displayed remarkable activity against multiple human cancer cell lines characterized by various KRAS mutations....

Continue Reading
ClubLink Expands Portfolio with Deer Creek Acquisition

Updated Category News Views 670

ClubLink Enhances Offerings with Deer Creek Purchase ClubLink Corporation ULC, the premier operator and manager of golf and country clubs in Canada, has recently made an exciting move by acquiring Deer Creek, a notable 45-hole golf and event complex. This impressive acquisition occurred for a substantial purchase price of $45,000,000, marking a significant growth...

Continue Reading
2025: A Defining Year for AI Adoption, Evercore Predicts Impact

Updated Category News Views 499

The Pivotal Year for AI Adoption As industries worldwide increasingly embrace artificial intelligence (AI), Evercore ISI points to 2025 as a transformative year for its adoption. The enthusiasm surrounding AI continues to escalate, yet clear indicators illustrate that widespread implementation has not yet reached full scale. Current Landscape of AI Adoption Despite a...

Continue Reading